Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs

Gastroenterology

Volumn 140, Issue 1, 2011, Pages 51-64.e2

  Snchezfueyo, Alberto ^a   Strom, Terry B ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Costimulation Blockade; Immunosuppression Weaning; Operational Tolerance; Regulatory T Cells

Indexed keywords

ARTICLE; CELLULAR IMMUNITY; GRAFT FAILURE; HISTOCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MEMORY T LYMPHOCYTE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 78650424492     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.10.059     Document Type: Review

References (154)

1. I. Stefanova, J.R. Dorfman, and M. Tsukamoto On the role of self-recognition in T cell responses to foreign antigen Immunol Rev 191 2003 97 106
2. B. Afzali, R.I. Lechler, and M.P. Hernandez-Fuentes Allorecognition and the alloresponse: clinical implications Tissue Antigens 69 2007 545 556
3. B. Afzali, G. Lombardi, and R.I. Lechler Pathways of major histocompatibility complex allorecognition Curr Opin Organ Transplant 13 2008 438 444
4. T.B. Strom, N.L. Tilney, and C.B. Carpenter Identity and cytotoxic capacity of cells infiltrating renal allografts N Engl J Med 292 1975 1257 1263
5. M. Sarwal, M.S. Chua, and N. Kambham Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling N Engl J Med 349 2003 125 138 (Pubitemid 36818782)
6. A. Kroemer, K. Edtinger, and X.C. Li The innate natural killer cells in transplant rejection and tolerance induction Curr Opin Organ Transplant 13 2008 339 343
7. F. Li, M.E. Atz, and E.F. Reed Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways Curr Opin Immunol 21 2009 557 562
8. A. Seetharam, V. Tiriveedhi, and T. Mohanakumar Alloimmunity and autoimmunity in chronic rejection Curr Opin Organ Transplant 15 2010 531 536
9. B.J. Nankivell, and J.R. Chapman Chronic allograft nephropathy: current concepts and future directions Transplantation 81 2006 643 654
10. J.G. O'Grady Phenotypic expression of recurrent disease after liver transplantation Am J Transplant 10 2010 1149 1154
11. J. Sprent, and C.D. Surh T cell memory Annu Rev Immunol 20 2002 551 579
12. M. Merkenschlager, and P.C. Beverley Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1) Int Immunol 1 1989 450 459
13. R.C. Budd, J.C. Cerottini, and C. Horvath Distinction of virgin and memory T lymphocytes Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation J Immunol 138 1987 3120 3129
14. D.L. Wallace, and P.C. Beverley Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells Immunology 69 1990 460 467
15. F. Sallusto, D. Lenig, and R. Forster Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
16. R.L. Hengel, V. Thaker, and M.V. Pavlick Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen J Immunol 170 2003 28 32
17. F. Sallusto, A. Langenkamp, and J. Geginat Functional subsets of memory T cells identified by CCR7 expression Curr Top Microbiol Immunol 251 2000 167 171
18. D.L. Barber, E.J. Wherry, and R. Ahmed Cutting edge: rapid in vivo killing by memory CD8 T cells J Immunol 171 2003 27 31
19. F. Sallusto, J. Geginat, and A. Lanzavecchia Central memory and effector memory T cell subsets: function, generation, and maintenance Annu Rev Immunol 22 2004 745 763
20. A.W. Bingaman, and D.L. Farber Memory T cells in transplantation: generation, function, and potential role in rejection Am J Transplant 4 2004 846 852
21. R.M. Welsh, and L.K. Selin No one is naive: the significance of heterologous T-cell immunity Nat Rev Immunol 2 2002 417 426
22. Z. Wu, S.J. Bensinger, and J. Zhang Homeostatic proliferation is a barrier to transplantation tolerance Nat Med 10 2004 87 92
23. X.X. Zheng, T.G. Markees, and W.W. Hancock CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment J Immunol 162 1999 4983 4990
24. A.D. Schenk, T. Nozaki, and M. Rabant Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients Am J Transplant 8 2008 1652 1661
25. J.P. Pearl, J. Parris, and D.A. Hale Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion Am J Transplant 5 2005 465 474
26. M.D. Vu, M.R. Clarkson, and H. Yagita Critical, but conditional, role of OX40 in memory T cell-mediated rejection J Immunol 176 2006 1394 1401
27. A.B. Adams, M.A. Williams, and T.R. Jones Heterologous immunity provides a potent barrier to transplantation tolerance J Clin Invest 111 2003 1887 1895
28. K. Araki, A.P. Turner, and V.O. Shaffer mTOR regulates memory CD8 T-cell differentiation Nature 460 2009 108 112
29. I. Koyama, O. Nadazdin, and S. Boskovic Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft Am J Transplant 7 2007 1055 1061
30. A. Valujskikh, B. Pantenburg, and P.S. Heeger Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice Am J Transplant 2 2002 501 509
31. P.S. Heeger, N.S. Greenspan, and S. Kuhlenschmidt Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes J Immunol 163 1999 2267 2275
32. O. Bestard, P. Nickel, and J.M. Cruzado Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients J Am Soc Nephrol 19 2008 1419 1429
33. T.B. Strom, and M. Koulmanda Recently discovered T cell subsets cannot keep their commitments J Am Soc Nephrol 20 2009 1677 1680
34. E. Bettelli, Y. Carrier, and W. Gao Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
35. T. Korn, E. Bettelli, and W. Gao IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells Nature 448 2007 484 487
36. C.T. Weaver, and R.D. Hatton Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective Nat Rev Immunol 9 2009 883 889
37. T.B. Strom, P. Roy-Chaudhury, and R. Manfro The Th1/Th2 paradigm and the allograft response Curr Opin Immunol 8 1996 688 693
38. X.C. Li, M.S. Zand, and Y. Li On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses J Immunol 161 1998 2241 2247
39. B.M. Hall, N.W. Pearce, and K.E. Gurley Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine III. Further characterization of the CD4+ suppressor cell and its mechanisms of action J Exp Med 171 1990 141 157
40. S. Sakaguchi, N. Sakaguchi, and M. Asano Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
41. H. Waldmann, T.C. Chen, and L. Graca Regulatory T cells in transplantation Semin Immunol 18 2006 111 119
42. P. Mitchell, B. Afzali, and G. Lombardi The T helper 17-regulatory T cell axis in transplant rejection and tolerance Curr Opin Organ Transplant 14 2009 326 331
43. H.J. Koenen, R.L. Smeets, and P.M. Vink Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells Blood 112 2008 2340 2352
44. J.S. Stumhofer, J.S. Silver, and A. Laurence Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 Nat Immunol 8 2007 1363 1371
45. L. Chen, E. Ahmed, and T. Wang TLR signals promote IL-6/IL-17-dependent transplant rejection J Immunol 182 2009 6217 6225
46. B. Kruger, S. Krick, and N. Dhillon Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation Proc Natl Acad Sci U S A 106 2009 3390 3395
47. M. Koulmanda, M. Bhasin, and L. Hoffman Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice Proc Natl Acad Sci U S A 105 2008 16242 16247
48. E.C. Lewis, M. Mizrahi, and M. Toledano alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice Proc Natl Acad Sci U S A 105 2008 16236 16241
49. R. Billingham, L. Brent, and P. Medawar Acquired immunological tolerance to foreign cells Nature 172 1953 603 606
50. J. Ashton-Chess, M. Giral, and S. Brouard Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation Transplantation 84 2007 1215 1219
51. X.C. Li, T.B. Strom, and L.A. Turka T cell death and transplantation tolerance Immunity 14 2001 407 416
52. Y. Li, X.C. Li, and X.X. Zheng Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance Nat Med 5 1999 1298 1302
53. A.D. Wells, X.C. Li, and Y. Li Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance Nat Med 5 1999 1303 1307
54. Z. Fan, J.A. Spencer, and Y. Lu In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response Nat Med 16 2010 718 722
55. M. Kern, A. Popov, and C. Kurts Taking off the brakes: T cell immunity in the liver Trends Immunol 31 2010 311 317
56. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163
57. J. Lerut, and A. Sanchez-Fueyo An appraisal of tolerance in liver transplantation Am J Transplant 6 2006 1774 1780
58. G. Tisone, G. Orlando, and A. Cardillo Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence J Hepatol 44 2006 702 709
59. J.M. Grinyo, and J.M. Cruzado Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress Am J Transplant 9 2009 2447 2452
60. P.F. Halloran Immunosuppressive drugs for kidney transplantation N Engl J Med 351 2004 2715 2729
61. M.D. Stegall, and J.M. Gloor Deciphering antibody-mediated rejection: new insights into mechanisms and treatment Curr Opin Organ Transplant 15 2010 8 10
62. F. Vincenti, B. Charpentier, and Y. Vanrenterghem A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) Am J Transplant 10 2010 535 546
63. A.D. Kirk Meteorology and tolerance Am J Transplant 6 2006 645 646
64. P.F. Halloran, J. Bromberg, and B. Kaplan Tolerance versus immunosuppression: a perspective Am J Transplant 8 2008 1365 1366
65. A.W. Thomson, G.V. Mazariegos, and J. Reyes Monitoring the patient off immunosuppression Conceptual framework for a proposed tolerance assay study in liver transplant recipients Transplantation 72 2001 S13 S22
66. T. Kawai, A.B. Cosimi, and T.R. Spitzer HLA-mismatched renal transplantation without maintenance immunosuppression N Engl J Med 358 2008 353 361
67. M.H. Sayegh, N.A. Fine, and J.L. Smith Immunologic tolerance to renal allografts after bone marrow transplants from the same donors Ann Intern Med 114 1991 954 955
68. C. Helg, B. Chapuis, and J.F. Bolle Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation Transplantation 58 1994 1420 1422
69. S. Matthes-Martin, C. Peters, and A. Konigsrainer Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis Blood 96 2000 3997 3999
70. C.H. Urban, A. Deutschmann, and R. Kerbl Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation Bone Marrow Transplant 30 2002 535 537
71. Z. Kadry, B. Mullhaupt, and E.L. Renner Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma Transplantation 76 2003 1003 1006
72. L.H. Buhler, T.R. Spitzer, and M. Sykes Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease Transplantation 74 2002 1405 1409
73. J.D. Scandling, S. Busque, and S. Dejbakhsh-Jones Tolerance and chimerism after renal and hematopoietic-cell transplantation N Engl J Med 358 2008 362 368
74. S.J. Knechtle, D. Vargo, and J. Fechner FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts Transplantation 63 1997 1 6
75. J.M. Thomas, D.M. Neville, and J.L. Contreras Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts Transplantation 64 1997 124 135
76. A.D. Kirk, D.A. Hale, and R.B. Mannon Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H) Transplantation 76 2003 120 129
77. A.D. Kirk, R.B. Mannon, and D.E. Kleiner Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin Transplantation 80 2005 1051 1059
78. R. Calne, P. Friend, and S. Moffatt Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients Lancet 351 1998 1701 1702
79. G. Ciancio, G.W. Burke, and J.J. Gaynor The use of Campath-1H as induction therapy in renal transplantation: preliminary results Transplantation 78 2004 426 433
80. S.J. Knechtle, J. Pascual, and D.D. Bloom Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring Am J Transplant 9 2009 1087 1098
81. R. Shapiro, M.L. Jordan, and A. Basu Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning Ann Surg 238 2003 520 525 discussion 525527
82. C.J. Watson, J.A. Bradley, and P.J. Friend Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantationefficacy and safety at five years Am J Transplant 5 2005 1347 1353
83. C. Benitez, I. Puig-Pey, and J.J. Lozano ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation Am J Transplant 10 2010 9
84. R. Girlanda, and A.D. Kirk Frontiers in nephrology: immune tolerance to allografts in humans J Am Soc Nephrol 18 2007 2242 2251
85. A.J. Demetris, J.G. Lunz III, and P. Randhawa Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective Transpl Int 22 2009 120 141
86. J. Devlin, D. Doherty, and L. Thomson Defining the outcome of immunosuppression withdrawal after liver transplantation Hepatology 27 1998 926 933
87. G.V. Mazariegos, J. Reyes, and I.R. Marino Weaning of immunosuppression in liver transplant recipients Transplantation 63 1997 243 249
88. J.A. Pons, B. Revilla-Nuin, and A. Baroja-Mazo FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal Transplantation 86 2008 1370 1378
89. J.A. Pons, J. Yelamos, and P. Ramirez Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression Transplantation 75 2003 1045 1047
90. G. Orlando, T. Manzia, and L. Baiocchi The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months Transpl Immunol 20 2008 43 47
91. J.D. Eason, A.J. Cohen, and S. Nair Tolerance: is it worth the risk? Transplantation 79 2005 1157 1159
92. M. Takatsuki, S. Uemoto, and Y. Inomata Weaning of immunosuppression in living donor liver transplant recipients Transplantation 72 2001 449 454 (Pubitemid 32769631)
93. P. Tryphonopoulos, A.G. Tzakis, and D. Weppler The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation Am J Transplant 5 2005 608 613
94. R. Girlanda, M. Rela, and R. Williams Long-term outcome of immunosuppression withdrawal after liver transplantation Transplant Proc 37 2005 1708 1709 (Pubitemid 40790804)
95. N. Assy, P.C. Adams, and P. Myers Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid Transplantation 83 2007 1571 1576 (Pubitemid 46987908)
96. C. Benitez, J.J. Lozano, and M. Martnez-Llordella Use of transcriptional biomarkers to identify liver transplant recipients who can successfully discontinue immunosuppressive therapy (abstr 213) Paper presented at: American Transplant Congress; May 20-Jun 3, 2009; Boston, MA Am J Transplant 9 2009 252
97. S. Feng, U. Ekong, and S. Lobritto ITN029ST: Immunosuppression withdrawal in pediatric recipients of parental living donor liver transplants: preliminary results of a pilot study (abstr 189) Paper presented at: American Transplant Congress; Boston, MA; May 30-Jun 3, 2009 Am J Transplant 9 2009 244
98. A.J. Demetris, O. Adeyi, and C.O. Bellamy Liver biopsy interpretation for causes of late liver allograft dysfunction Hepatology 44 2006 489 501
99. T. Wong, K.T. Nouri-Aria, and J. Devlin Tolerance and latent cellular rejection in long-term liver transplant recipients Hepatology 28 1998 443 449
100. C. Benitez, J.J. Lozano, and M. Martinez-Llordella Use of transcriptional biomarkers to identify liver transplant recipients who can successfully discontinue immunosuppressive therapy (abstr 517) Am J Transplant 10 2010 191
101. G. Tisone, G. Orlando, and G. Palmieri Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence J Hepatol 44 2006 702 709
102. G.V. Mazariegos, R. Sindhi, and A.W. Thomson Clinical tolerance following liver transplantation: long term results and future prospects Transpl Immunol 17 2007 114 119
103. M. Yoshitomi, T. Koshiba, and H. Haga Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation Transplantation 87 2009 606 614
104. L.M. Vasconcellos, A.D. Schachter, and X.X. Zheng Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts Transplantation 66 1998 562 566
105. B. Li, C. Hartono, and R. Ding Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine N Engl J Med 344 2001 947 954
106. T. Muthukumar, D. Dadhania, and R. Ding Messenger RNA for FOXP3 in the urine of renal-allograft recipients N Engl J Med 353 2005 2342 2351
107. D. Dadhania, T. Muthukumar, and R. Ding Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection Transplantation 75 2003 1752 1754
108. R. Ding, B. Li, and T. Muthukumar CD103 mRNA levels in urinary cells predict acute rejection of renal allografts Transplantation 75 2003 1307 1312
109. R.R. Tatapudi, T. Muthukumar, and D. Dadhania Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine Kidney Int 65 2004 2390 2397
110. M. Seiler, I. Brabcova, and O. Viklicky Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation Am J Transplant 7 2007 423 433
111. A. Shoker, D. George, and H. Yang Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection Transplantation 70 2000 497 505
112. F.J. Dugre, S. Gaudreau, and M. Belles-Isles Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection Transplantation 70 2000 1074 1080
113. N. Shulzhenko, A. Morgun, and G.F. Rampim Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans Hum Immunol 62 2001 342 347
114. M. Schoels, T.J. Dengler, and R. Richter Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells Clin Transplant 18 2004 513 517
115. A. Cashion, O. Sabek, and C. Driscoll Correlation of genetic markers of rejection with biopsy findings following human pancreas transplant Clin Transplant 20 2006 106 112
116. D. Han, X. Xu, and D. Baidal Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection Diabetes 53 2004 2281 2290
117. M.C. Deng, H.J. Eisen, and M.R. Mehra Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling Am J Transplant 6 2006 150 160
118. D. Bernstein, G.E. Williams, and H. Eisen Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients J Heart Lung Transplant 26 2007 1270 1280
119. M.R. Mehra, J.A. Kobashigawa, and M.C. Deng Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts J Heart Lung Transplant 26 2007 1255 1263
120. B.S. Lu, A.D. Yu, and X. Zhu Sequential gene expression profiling in lung transplant recipients with chronic rejection Chest 130 2006 847 854
121. J. Patil, J.D. Lande, and N. Li Bronchoalveolar lavage cell gene expression in acute lung rejection: development of a diagnostic classifier Transplantation 85 2008 224 231
122. C. Ashokkumar, A. Talukdar, and Q. Sun Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation Am J Transplant 9 2009 179 191
123. C. Ashokkumar, A. Gupta, and Q. Sun Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation Surgery 146 2009 166 173
124. S. Brouard, E. Mansfield, and C. Braud Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance Proc Natl Acad Sci U S A 104 2007 15448 15453
125. S. Louis, C. Braudeau, and M. Giral Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance Transplantation 81 2006 398 407
126. K.A. Newell, A. Asare, and A.D. Kirk Identification of a B cell signature associated with renal transplant tolerance in humans J Clin Invest 120 2010 1836 1847
127. P. Sagoo, E. Perucha, and B. Sawitzki Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans J Clin Invest 120 2010 1848 1861
128. M. Martinez-Llordella, I. Puig-Pey, and G. Orlando Multi-parameter of immune profiling of operational tolerance in liver transplantation Am J Transplant 7 2007 309 319
129. M. Martinez-Llordella, J.J. Lozano, and I. Puig-Pey Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients J Clin Invest 118 2008 2845 2857
130. M. Kawasaki, M. Iwasaki, and T. Koshiba Gene expression profile analysis of the peripheral blood mononuclear cells from tolerant living-donor liver transplant recipients Int Surg 92 2007 276 286
131. Y. Li, T. Koshiba, and A. Yoshizawa Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation Am J Transplant 4 2004 2118 2125
132. G.V. Mazariegos, A.F. Zahorchak, and J. Reyes Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression Am J Transplant 5 2005 314 322
133. Y. Li, X. Zhao, and D. Cheng The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients Transplantation 86 2008 1837 1843
134. X.X. Zheng, T.G. Markees, and W.W. Hancock CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment J Immunol 162 1999 4983 4990
135. T.A. Judge, Z. Wu, and X.G. Zheng The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival J Immunol 162 1999 1947 1951
136. C.P. Larsen, E.T. Elwood, and D.Z. Alexander Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways Nature 381 1996 434 438
137. E. Ozkaynak, W. Gao, and N. Shemmeri Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection Nat Immunol 2 2001 591 596
138. H. Harada, A.D. Salama, and M. Sho The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity J Clin Invest 112 2003 234 243
139. S.A. Quezada, L.Z. Jarvinen, and E.F. Lind CD40/CD154 interactions at the interface of tolerance and immunity Annu Rev Immunol 22 2004 307 328
140. C. Domenig, A. Sanchez-Fueyo, and J. Kurtz Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol J Immunol 175 2005 51 60
141. A. Sanchez-Fueyo, M. Weber, and C. Domenig Tracking the immunoregulatory mechanisms active during allograft tolerance J Immunol 168 2002 2274 2281
142. A. Yamada, A.D. Salama, and M. Sho CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo J Immunol 174 2005 1357 1364
143. G. Demirci, and X.C. Li Novel roles of OX40 in the allograft response Curr Opin Organ Transplant 13 2008 26 30
144. C. Mariat, N. Degauque, and S. Balasubramanian Tim-1 signaling substitutes for conventional signal 1 and requires costimulation to induce T cell proliferation J Immunol 182 2009 1379 1385
145. N. Degauque, C. Mariat, and J. Kenny Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice J Clin Invest 118 2008 735 741
146. N. Degauque, C. Mariat, and J. Kenny Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins Transplantation 84 2007 S12 S16
147. V.L. Perez, L. Van Parijs, and A. Biuckians Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement Immunity 6 1997 411 417
148. B. Salomon, and J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol 19 2001 225 252
149. S.E. Sandner, M.R. Clarkson, and A.D. Salama Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo J Immunol 174 2005 3408 3415
150. E. Ozkaynak, L. Wang, and A. Goodearl Programmed death-1 targeting can promote allograft survival J Immunol 169 2002 6546 6553
151. C. Kurts, F.R. Carbone, and M.F. Krummel Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells Nature 398 1999 341 344
152. Z. Dai, Q. Li, and Y. Wang CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism J Clin Invest 113 2004 310 317
153. A. Sanchez-Fueyo, J. Tian, and D. Picarella Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance Nat Immunol 4 2003 1093 1101
154. A.C. Anderson, D.E. Anderson, and L. Bregoli Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells Science 318 2007 1141 1143